Mathur Sunil, Hoskins Clare
Molecular Drug Research Laboratory, Edinburgh Napier University, Edinburgh EH11 4BN, UK.
Institute of Science and Technology in Medicine, Keele University, Hartshill, Stoke-on-Trent ST4 7QB, UK.
Biomed Rep. 2017 Jun;6(6):612-614. doi: 10.3892/br.2017.909. Epub 2017 May 9.
Natural products have been acknowledged for numerous years as a vital source of active ingredients in therapeutic agents. In particular, the use of active ingredients derived from plants for use in microbial natural products have long been used before the dawn of modern medicine. From ancient times, the efficacy of natural products has been associated with the chemistry, biochemistry and synthetic activities of natural products. Thus, with scientific advancement in modern molecular and cellular biology, analytical chemistry and pharmacology, the unique properties of these natural products are being harnessed in order to exploit the chemical and structural diversity and biodiversity of these types of products in relation to their therapeutic effect. Often, new molecules of interest in drug design units focus on the rearrangement of chemical entities or structural isomers of naturally occurring products in order to generate new molecules; these may be formulated into clinically useful therapies.
多年来,天然产物一直被公认为治疗药物中活性成分的重要来源。特别是,源自植物的活性成分用于微生物天然产物的应用早在现代医学出现之前就已长期使用。自古以来,天然产物的功效就与天然产物的化学、生物化学和合成活性相关联。因此,随着现代分子和细胞生物学、分析化学和药理学的科学进步,这些天然产物的独特性质正被加以利用,以便在其治疗效果方面开发这类产品的化学和结构多样性以及生物多样性。通常,药物设计单元中感兴趣的新分子专注于天然存在产物的化学实体或结构异构体的重排,以生成新分子;这些新分子可以被配制成临床上有用的疗法。